Tailored plan for & Gut Health from the start to maintenance
“The most effective natural support for gut health."
-National Survey of leading IBD doctors, IL. 22.

A comprehensive, novel plant-based agent, CurQD® is clinically proven to support GI health. Developed by leading GI experts in Sheba Medical Center, one of Newsweek’s best 10 hospitals, we provide an online assessment and direct delivery of our product. The CurQD® Protocol offers significant results within 8-12 weeks and potential for long-term remission with no side effects according to RCTs.*
One of the great challenges in supporting gut health is that every individual’s system is unique and constantly evolving. The CurQD® Protocol offers a personalized approach designed to adapt to your body’s changing needs over time. This tailored plan provides both a structured starting phase and ongoing support for balanced, long-term gut wellness.
In a recent retrospective trial led by our research team in association with leading IBD centers, the strategic use of CurQD® doses resulted in 70.4% of patients with clinical response and 51.1% of patients in complete clinical remission.
This was even observed in patients failing biologics or corticosteroids, demonstrating the prowess of CurQD® as a potential nutraceutical therapy for unresponsive patients. Our top-grade clinical research demonstrates that by personalizing the therapy, we vastly improved patient outcomes.
70.4% of patients showed clinical response and 51.1% of patients showed clinical remission.

At week 8, 50% achieved clinical remission, and 85.7% achieved clinical response.
In a 2023 multi-center randomized controlled trial, UC patients who had all failed at least one line of pharmaceutical UC treatments were given CurQD®.
At week 8, 50% achieved clinical remission, and 85.7% achieved clinical response.
Our natural formulas contain molecules that activate a specific immunological pathway initiated by the aryl hydrocarbon receptor (AhR). When activated, this pathway accelerates the reconstitution of intestinal integrity and supports normal mucosal functioning.
Although the AhR pathway was previously overlooked as a potential target, it is now the main focus of emerging novel nutritional interventions. CurQD® is the first formulation shown in clinical trials to support gut health through the activation of this pathway.

The CurQD® Protocol was developed by Professor Shomron Ben-Horin (MD) and Nir Salomon (C.Ac, C.Hb) in Sheba Medical Center, one of Newsweek’s best 10 hospitals in the world.
Ben-Horin and Salomon have spearheaded the research and development of nutraceuticals for GI Health over the last decade. Their breakthrough CurQD® nutritional intervention is currently the most effective natural strategy for supporting gut health and has been successfully integrated into the clinical practice of leading GI medical centers in Israel.
Integrative Gastroenterology Specialist, Founder and Director of the Integrative Gastroenterology unit at Sheba Medical Center. Nir has been conducting research across world-leading medical centers for the past decade and continues to develop novel nutraceutical therapies for GI diseases. He currently treats patients at his two private IBD clinics in Israel, whilst advocating integrative medical approaches around the world.
Chief of the Gastroenterology Department at Sheba Medical Center Tel-Aviv University, named by Newsweek magazine as one of the top 10 medical centers in the world for three consecutive years. Shomron Ben-Horin M.D. was previously a member of the Scientific Committee of the European Crohn’s and Colitis Organization (ECCO) and Chair of the Israeli IBD Society. He is currently a member of the prestigious International Organization of IBD (IOIBD).
*In our latest RCT, no serious adverse events were reported and all side effects were comparable to placebo. In our retrospective trial, the mild, transient, reversible elevation of liver enzymes was reported in 5% of patients.
For more information on adding CurQD® to your treatment, see our Guidelines for Healthcare Professionals.